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A B S T R A C T
Background: Current standard skin antisepsis to prevent surgical site infections are ineffective to eradicate all
skin-colonizing bacteria. Photodynamic therapy (PDT) has shown bactericidal effects in vitro, but no clinical
study with improvements in skin antisepsis has been documented.
Methods: We investigated the effect of methyl aminolevulinate (MAL)-PDT versus no PDT for skin antisepsis
treatment (povidone-iodine/alcohol) in the groin of 10 healthy participants. Skin swabs were taken at baseline,
immediately after PDT, and after skin antisepsis treatment to cultivate bacteria. At day 7 and 21, bacterial
cultures were repeated before and after antisepsis treatment without PDT. Skin biopsies were performed to
examine the grade of inflammation.
Results: Skin-colonizing bacteria were found in all 20 participants at baseline sampling. Immediately after MAL-
PDT, skin was sterile in 7 (70%) participants before and in all 10 (100%) participants after skin antisepsis
treatment. In contrast, we found skin-colonizing bacteria in 5 (50%) participants of the control group receiving
only skin antisepsis. After 7 and 21 days, skin sterility was similar to the baseline. We observed slight peri-
vascular inflammation with lymphocytes and eosinophils without changes in the histomorphology of eccrine or
sebaceous glands in skin biopsies. PDT was generally well tolerated except for localized redness.
Conclusion: MAL-PDT with skin antisepsis treatment sterilized skin immediately after its use but did not
maintain sterility 7–21 days post-treatment. Due to local side effects, further clinical studies with less intensive
PDT conditions or other photosensitizers are needed before PDT is integrated into clinical practice.
1. Introduction
The use of orthopedic implants has been steadily rising over the last
decade due to the growing demand for periprosthetic joints in the ex-
panding elderly population. Periprosthetic joint infections (PJI) are one
of the most feared complications after surgical intervention as these
infections have biofilm etiologies that are difficult to treat and impact
the quality of life, increasing health-care costs [1]. Within a mature
biofilm, bacteria are protected against most current antibiotics by a
coating of exopolysaccharide matrix, preventing antibiotic penetration
and by bacterial heterogeneity, decreasing available antibiotic targets
within bacteria. The most commonly isolated microorganisms in PJI are
staphylococci, streptococci, enterococci, Gram-negative bacteria, and
anaerobic bacteria such as Cutibacterium acnes/ Cutibacterium avidum
(formerly Propionibacterium acnes/ Propionibacterium avidum) [1,2], all
of which may inhabit the normal skin flora.
A majority of PJI are acquired during surgery, with the same bac-
teria that colonize the skin surface serving as infectious invaders of the
orthopedic implant [3]. Skin antisepsis at incision sites should be the
primary intervention to prevent commensal bacterial infection into
deep tissues during surgery. Recent studies have shown that the current
standards for skin antisepsis are not effective enough to sterilize the
skin before arthroplasty [4]. Lee et al. showed a significant growth rate
of C. acnes in 7 out of 10 volunteers with skin biopsies, despite skin
preparation with chlorhexidine/alcohol prior to sampling [5]. Maurer
et al. detected bacterial growth of skin commensals after standard
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antisepsis in the groin in 50% of the patients (manuscript in review,
oral communication FP 81 at the European Bone and Joint Infection
Society (EBJIS) meeting, Antwerp, 2019). Different approaches to im-
prove antisepsis have been examined throughout the years, some with
no effects [4] and others with promising results [6,7]. Local antibiotics
risk the emergence of bacterial resistance, making this approach un-
desirable in daily surgical practice [8].
The antimicrobial effect of photodynamic therapy (PDT) has already
been established in previous studies and relies on photophysical and
photochemical reactions to eliminate bacteria [9,10]. We hypothesize
that PDT reduces the growth of skin-colonizing bacteria when com-
bined with skin antisepsis treatment, the latter already being routinely
performed prior to arthroplasty surgeries. Therefore, we evaluated the
effect of PDT with methyl aminolevulinate (MAL) as the prodrug for the
photosensitizer protoporphyrin IX (Pp IX) on skin-colonizing bacteria in
a pilot study with 10 healthy participants. Promising results will pro-
vide the basis for planning a future clinical study in an orthopedic
center. Since PDT triggers subtle skin inflammation which may be
suboptimal for immediate surgery, we evaluated the effect of PDT at
baseline, immediately after PDT and skin antisepsis treatment, and after
7 and 21 days analyzing bacterial growth and severity of skin in-
flammation.
2. Materials and methods
2.1. Participants and study design
In this single center clinical trial, healthy male and female partici-
pants (≥ 18 years) were recruited to have PDT in combination with
skin antisepsis. The study was approved by the local ethical committee
(BASEC Nr 2019-00252) and an informed consent was obtained from
each participant prior to treatment. From September-November 2019,
we enrolled 10 healthy participants for PDT and another 10 healthy
participants for the control group to be treated with skin antisepsis
only. We excluded pregnant and lactating women, participants unable
to follow instructions of the study leaders (e.g. language problems,
psychological disorders, dementia, etc), taking antibiotics 14 days prior
to PDT or until follow-up at day 14, receiving oral retinoid therapy
within the last 6 months or anti-inflammatory agents such as Non-
Steroidal Anti-Inflammatory Drugs within 14 days prior and after PDT,
taking any photosensitizing drugs within 4 weeks prior to PDT, and
those who had a history of photosensitive disorder or Fitzpatrick’s skin
phototype VeVI.
Participant characteristics such as age, BMI, comorbidities, aller-
gies, and medication were recorded for all 20 participants on the first
day of their clinical visit. The study design for both groups is shown in
Fig. 1. For all 10 participants receiving PDT treatment, skin swabs were
immediately taken before and after PDT and after standard skin anti-
sepsis treatment on days 0, 7, and 21 to investigate the amount of
bacterial species on human skin. All study participants had follow-up
examinations to evaluate the extent of skin inflammation after PDT.
Participants were specifically asked about any redness, pain, skin irri-
tation and itching, other abnormalities, and the need for medications
for relief from symptoms. In a subgroup of patients, additional dermis
biopsies of the treated groin area were taken immediately after PDT,
after 7 days, and again after 21 days. A biopsy from the opposite, un-
treated side of the body was used as a control.
2.2. Skin swabs
Skin swabs were taken from the right groin area, immediately below
the anterior superior iliac spine with sterile blades scraping at a 45°
angle. Material was removed carefully from the blade and inoculated
into an eSwab Collection and Transport System (Copan, Italy). All
Fig. 1. Study design for 10 participants receiving PDT and 10 control participants.
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swabs were analyzed for bacterial growth at the Institute of Medical
Microbiology of the University of Zurich. All skin swabs (1–7) were
carried out using the same technique.
2.3. Photodynamic therapy (PDT)
PDT requires three elements: a photosensitizer, visible light with a
specific wavelength to excite the photosensitizer, and tissue oxygen.
Reactive oxygen species that induce antimicrobial effects by oxidative
damage are generated after absorption of a suitable wavelength of light
by a photosensitizer in the presence of tissue oxygen [11–13]. MAL is an
ester of 5-aminolevulinic acid (5-ALA) which can be found in nearly all
bacterial and human cells as a component of the heme biosynthesis
pathway. Accumulation of photoactive porphyrins in targeted cells can
Fig. 2. Effect of photodynamic therapy (PDT) treatment on specific bacterial species. Panel A: Number of positive samples on day 0 (day of PDT) at baseline (blue),
after PDT (red) and after skin antisepsis treatment (AS) (green). Panel B: Number of positive samples 7 days after the PDT before AS (blue) and after AS (green). Panel
C: Number of positive samples after 21 days of PDT before AS (blue) and after AS (green). D: Number of positive samples in the control group before AS (blue) and
after AS (green).
“Others” included:
Others1 Staphylococcus lugdunensis, C. avidum, Mircococcus flavus, Bacillus cereus, Anaerococcus sp., Dermobacter hominis.
Others2 Corynebacterium kroppenstedtii
Others3 S. lugdunensis,Corynebacterium sp. Corynebacteriumaurimucosum, Bacillussp.
Others4 Staphylococcus aureus, Corynebacterium sp. Corynebacterium jeikeium, D. hominis
* Staphylococcus haemolyticus, Staphylococcus saprophyticus, Staphylococcussp.
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be achieved by providing it exogenously [9]. Cells with a high meta-
bolic rate such as neoplastic cells and bacteria will accumulate 5-ALA
more intensely [14]. 5-ALA has already been used in clinical studies,
specifically for PDT treatment of C. acnes bacterial biofilms in sebac-
eous glands [15–18]. Using MAL-PDT in our study, we aimed to reach
not only superficial skin-colonizing bacteria, but also eccrine glands
acting as a reservoir of bacteria [15,19,20] that are not affected by
topical skin antisepsis treatment.
PDT treatment was performed at the Division of Dermatology of the
University Hospital of Zurich. MAL (Metvix®, Galderma SA, Tube 2 g)
was applied in a sheer layer over the right groin area, covered by a
light-impermeable bandage, and allowed to incubate before PDT for 3
h. The area was then exposed to a 633 nm diode (LED; Healite II®;
Lutronic; Billerica, MA, USA) for 13 min with an energy dose of 40 J/
cm2. Photographic documentation of treated skin was made before and
after PDT.
2.4. Skin antisepsis with povidone-iodine/alcohol
Antisepsis treatment of the groin was performed 3 times according
to standard operation room procedure using Betaseptic (povidone-io-
dine/alcohol) with at least one-minute interval in between placement.
2.5. Biopsies for dermatohistopathology
In four participants, 4 mm skin punch biopsies of the right groin
were taken directly after PDT (n = 2) or one week after PDT (n = 2),
and again after 3 weeks (n = 4). As a control sample, a similar punch
biopsy was taken from the left untreated groin in the same participants
(n = 4). Skin biopsies were fixed in formalin and embedded in paraffin.
Sections were sliced 4 μm thick for hematoxylin and eosin staining and
assessed for the presence of inflammation in the perivascular com-
partment, focusing on areas with eccrine sweat glands and sebaceous
glands. In those specimens with inflammation, the type and amount of
inflammatory cells (lymphocytes, neutrophils, eosinophils) were as-
sessed.
2.6. Microbiology
Skin swabs were evaluated for any bacterial growth using Columbia
sheep blood agar plates without antibiotics (bioMérieux, Mary-l’Etoile,
France) and colistin-nalidixic acid blood agar (bioMérieux, Mary-
l’Etoile, France) plates for aerobic cultivation. Brucella agar plates (in-
house sheep blood agar plates with hemin added Vitamin K1 provided
by the Institute of Clinical Microbiology, Zurich, Switzerland) were
used for anaerobic cultivation with GENbags (bioMérieux, Mary-
l’Etoile, France). Cultures were left for at least 7 days at 37 °C to check
for persisters. Each suspicious bacterial colony was analyzed for bac-
terial identification using matrix assisted laser desorption ionization-
time of flight mass spectrometry (MALDI-TOF MS).
3. Results
Half of our included healthy participants in the study (5 out of 10)
receiving PDT treatment were female with a median age of 30 years
(range 21–54 years) and a median BMI of 22.3 kg/m2 (19.0–24.9 kg/
m2). Demographic characteristics were similar in the control group
without PDT [(7 female, median age of 30 years (range, 22–50 years),
and a median BMI of 25.02 kg/m2 (range, 18.6–26.8 kg/m2)].
3.1. Culture results
In the PDT group, all 10 participants were colonized with different
bacteria such as coagulase-negative staphylococci (Staphylococcus ca-
prae/capitis, Staphylococcus epidermidis, Staphylococcus hominis,
Staphylococcus warneri/pasteuri), C. acnes, Micrococcus luteus, and others
at baseline (Fig. 2A). Immediately after MAL-PDT, skin was culturally
sterile in 7 (70%) participants. In the remaining 3 participants, we
observed bacterial growth of S. epidermidis, S. hominis and/or C. acnes.
After further skin antisepsis treatment, we achieved complete sterility
in all 10 participants (Fig. 2A, Table 1).
The effect of MAL-PDT on skin antisepsis did not last 1 or 3 weeks
post-treatment, with skin sterility after antisepsis decreasing to 62.2%
and 40%, respectively. This was similar to the control group, where we
obtained sterility in 50% by performing skin antisepsis treatment only
(Table 1). Almost all tested bacterial species recolonized within 7–21
days in varying amounts, with C. acnes presenting most frequently. In
addition, Corynebacterium tuberculostearicum was immediately detected
after 7 and 21 days. Skin antisepsis reduced the amount of all re-
colonized bacteria but did not eradicate them completely (Fig. 2B-C).
We did not perform statistical analysis due to low patient numbers and
did not investigate for the presence of antibiotic resistance.
3.2. Histopathology
In skin biopsies, all specimens showed slight inflammation with
lymphocytes and eosinophils presenting immediately after PDT on day
0 in the perivascular compartment (n = 2) (Table 2, Fig. 3). There was
no inflammation around eccrine sweat glands or around sebaceous
glands. After 7 days, similar lymphocytic and eosinophilic presence was
detected in the perivascular compartment in one of two participants;
this participant had also inflammation with lymphocytes and eosino-
phils around eccrine sweat glands. Aside from inflammatory infiltrate,
Table 1
Skin sterility (defined as no viable bacteria using conventional cultures) before
and after PDT treatment and following skin antisepsis treatment.
Sterlity Nr/Nr total (%)
Day 0, control group without PDT, n = 10
Before antisepsis (Skin swab 1) 0/10 (0)
After antisepsis (Skin swab 3) 5/10 (50)
Day 0, PDT treatment, n = 10
Baseline (Skin swab 1) 0/10 (0)
After PDT (Skin swab 2) 7/10 (70)
After PDT and antisepsis (Skin swab 3) 10/10 (100)
Day 7 after PDT, n = 8
Before antisepsis (Skin swab 4) 0/8 (0)
After antisepsis (Skin swab 5) 5/8 (62.5)
Day 21 after PDT, n = 10
Before antisepsis (Skin swab 6) 0/10 (0)
After antisepsis (Skin swab 7) 4/10 (40)
Table 2
Histological assessment of skin inflammation.
Nr/Nr total (%)
Day 0, control group, n = 4
Perivascular inflammation 0/4 (0)
Inflammation around eccrine sweat glands 0/4 (0)
Inflammation around sebaceous glands 0/4 (0)
Day 0, immediately after PDT, n = 2
Perivascular inflammation 0/2 (100)
lymphocytes (2/2), eosinophils (1/2), neutrophils (0/2)
Inflammation around eccrine sweat glands 0/2 (0)
Inflammation around sebaceous glands 0/2 (0)
Day 7, n = 2
Perivascular inflammation 1/2 (50)
lymphocytes (1/2), eosinophils (1/2), neutrophils (0/2)
Inflammation around eccrine sweat glands 1/2 (50)
lymphocytes (1/2), eosinophils (1/2), neutrophils (0/2)
Inflammation around sebaceous glands 0/2 (0)
Day 21, n = 4
Perivascular inflammation 0/4 (0)
Inflammation around eccrine sweat glands 0/4 (0)
Inflammation around sebaceous glands 0/4 (0)
I. Waldmann, et al. Photodiagnosis and Photodynamic Therapy 31 (2020) 101941
4
no changes in the histomorphology of sweat glands or sebaceous glands
could be observed. After 21 days, inflammation had completely dis-
appeared in all participants (n = 4). The untreated control biopsies
from the left groin showed no inflammation throughout the treatment
(n = 4).
3.3. Side effects of PDT
PDT was generally well tolerated. Side effects (localized redness)
were slight and temporary. All participants reported slight redness
(Grade 1 according CTCAE V5) during and after PDT, which resolved
within 7 days after the treatment (Table 3, Supplementary Figure S1).
Seven out of 10 participants reported a slight sensation of burning
(Grade 1–2 according CTCAE V5) during PDT, which was comforted
with a cooling water spray during the treatment. Itching was only re-
ported by 3 participants during the follow-up period but not during PDT
(Table 3).
4. Discussion
We demonstrated that MAL-PDT in combination with standard skin
antisepsis treatment completely inhibited bacterial growth of skin-co-
lonizing bacteria in the groin area of 10 healthy participants. Skin an-
tisepsis or PDT monotherapy achieved less sterility compared to
combination therapy with skin antisepsis. However, the effect of PDT
on skin antisepsis did not last until 7 or 21 days. Recolonization was
represented mostly by S. epidermidis and C. acnes, common skin com-
mensals [21] associated with PJI [1]. Based on these results, MAL-PDT
would be a promising tool when used on the day of surgery to eliminate
the skin microbiome. However, using PDT with topical MAL cream led
to transient skin erythema, possibly from the MAL prodrug that induces
the photosensitizing agent Pp IX, which is an obstacle for immediate
surgery.
Achieving 100% skin sterility with MAL-PDT and skin antisepsis
treatment is an extremely promising study outcome compared to the
50% sterility witnessed using skin antisepsis treatment alone. Bryld and
Jemec investigated if using PDT with MAL as a prodrug for the pho-
tosensitizer Pp IX could change the normal skin flora in patients un-
dergoing standard PDT for skin disease treatment but reported no sig-
nificant effects [22]. Compared to 5-ALA, MAL has been shown to have
a more selective and deeper distribution of photoactive porphyrins in
thick basal cell carcinomas [23] and sebaceous glands [19], with less
systemic uptake and pain during irradiation [24]. We chose MAL (ester
of 5-ALA) in combination with a red-light source at a wavelength of 633
nm to penetrate deeper into the skin layers and target eccrine glands.
Skin biopsies from our participants only demonstrated slight perivas-
cular inflammation immediately after PDT but no changes to eccrine or
sebaceous glands [25]. Previous investigation by Itoh et al. described a
slight decrease of nuclei of sebaceous glands. Repeated PDT sessions
may therefore be necessary to successfully attack all sebaceous or ec-
crine glands [26].
We documented some mild side effects (local redness, burning
sensation) during and after irradiation, resolving within 1 week, co-
ordinating with previous literature [19,25,27,28]. In patients treated
for acne, lesions returned to normal skin tone without hy-
perpigmentation after 1 month [25]. The skin redness after irradiation
might be a limiting factor for surgeons concerned with proper wound
Fig. 3. Exemplary histology images noted during PDT. A: Slight perivascular inflammation immediately after PDT (visit 0). B: Close up view of slight perieccrine
inflammation 7 days after PDT. C: Close up view of slight perivascular inflammation consisting of lymphocytes and eosinophils 7 days after PDT. D: Untreated control
without inflammation.
Table 3
Side effects during and after MAL-PDT in 10 participants.
Side effects Nr (%) during PDT Nr (%) after PDT
Redness Grade 1 10 (100) 10 (100)*
Skin irritation (burning, tingling) 7 (70) 5 (50)
Itching 0 (0) 3 (30)
* up to 7 days.
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healing. However, our histological analysis of the dermis showed only a
slight immediate or delayed inflammation, favoring the use of PDT and
does not exclude it as a potential prevention strategy. Hence, more
studies are needed to determine the optimal time point for PDT prior to
surgery to achieve the maximum bactericidal effect with an acceptable
local skin reaction. MAL-PDT with less irradiance intensity, reduced
duration of the treatment, or other photosensitizers could be tested to
minimize local erythema while maintaining the same bactericidal ef-
fect. Alternatively, a skin cream with human growth factors and cyto-
kines has been discussed to treat phototoxicity after PDT [29]. Recently,
PDT using daylight was presented as a pain free approach to treat ac-
tinic keratosis [30]. This could be advantageous over artificial light and
decrease skin irritation.
Our evaluation for skin commensals was through conventional
bacterial culture derived from skin swabs. This took us at a minimum 7
days until we were able to observe and identify colonies. Molecular
techniques as real time PCR could facilitate the detection directly from
tissue samples since its multiplexing capability allows rapid amplifi-
cation of several bacteria simultaneously [31–33]. However, molecular
techniques cannot distinguish between viable and non-viable bacteria,
requiring the need for live culture techniques.
This pilot study is the first that examines the effect of PDT on the
skin microbiome as an improved implant-associated infection preven-
tion strategy in arthroplasty surgery. The ability to achieve 100%
sterility immediately after MAL-PDT and skin antisepsis treatment is
striking. However, it should be noted that our study population was
small and participants were younger than the average age of patients
undergoing arthroplasty surgery, hence larger studies within ortho-
pedic wards are needed to further evaluate our study results. Since
different approaches to improve skin antisepsis have been performed so
far with no promising effect [4] or may lead to emergence of bacterial
resistance [4,8,28], we are convinced that a strategy with an improved
skin antisepsis with PDT can provide superior results to decrease PJI.
To conclude, MAL-PDT has an immediate bactericidal effect on the
skin microbiome in the groin area. Due to local side effects, more
clinical studies with modulation of MAL-PDT, such as decreased light
exposure, shorter irradiation time, or other photosensitizers, are
needed.
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